Related Experiment Video

Updated: Jul 3, 2026

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
12:34

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on: January 12, 2024

New visions for atopic eczema: an iPAC summary and future trends

Fabienne Rancé1, Mark Boguniewicz, Susanne Lau

  • 1Hôpital des Enfants, Toulouse, France. rance.f@chu-toulouse.fr

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|August 2, 2008
PubMed

Insights

Atopic eczema (AE) is a common childhood skin condition causing itching and dry skin. Research highlights its genetic links to skin barrier function and immune responses, guiding future understanding and treatment.

Area of Science:

  • Dermatology
  • Genetics
  • Immunology

Background:

  • Atopic eczema (AE) is a chronic inflammatory skin condition prevalent in children (15-20%).
  • AE presents with characteristic pruritus, dry skin, and cyclical exacerbations and remissions.
  • A strong familial predisposition suggests a significant genetic component in AE development.

Purpose of the Study:

  • To discuss recent advancements in understanding the pathogenesis of atopic eczema.
  • To review current diagnostic approaches and the natural course of the disease.
  • To explore future directions in AE research, including prognosis and therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on atopic eczema.
  • Focus on genetic factors influencing skin barrier and immune responses.
  • Discussion of clinical observations regarding disease progression.

Main Results:

  • Identification of key genes involved in skin barrier/epidermal differentiation.
  • Highlighting the role of immune response and host defense genes in AE.
  • Synthesis of current knowledge on AE pathogenesis and clinical features.

Conclusions:

  • Atopic eczema is a complex genetic disorder impacting skin barrier and immunity.
  • Further research into specific genes and pathways is crucial for improved diagnostics and treatments.
  • Understanding disease natural course and prognosis aids in patient management.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.